Sunshine Biopharma (SBFM) said Monday its Canadian unit Nora Pharma has launched a generic version of Everolimus in Canada.
The company said the drug is a substitute for Afinitor and is used to treat certain types of cancer, including advanced kidney cancer, certain breast cancers, and specific neuroendocrine tumors.
The product is available in 2.5 mg, 5 mg, and 10 mg tablet doses, Sunshine said.
Shares of the company were up more than 16% in recent Monday premarket activity.
Price: 1.46, Change: +0.21, Percent Change: +16.84
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。